Mogamulizumab-kpkc Intravenous and Sumatriptan and naproxen
Determining the interaction of Mogamulizumab-kpkc Intravenous and Sumatriptan and naproxen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: naproxen / sumatriptan
Brand name: Treximet
Synonyms: Sumatriptan and Naproxen
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Sumatriptan injection
- Mogamulizumab-kpkc Intravenous-Sumatriptan Nasal Powder
- Mogamulizumab-kpkc Intravenous-Sumatriptan Nasal Spray
- Mogamulizumab-kpkc Intravenous-Sumatriptan Nasal, Oral, Subcutaneous
- Mogamulizumab-kpkc Intravenous-Sumatriptan oral/nasal
- Mogamulizumab-kpkc Intravenous-Sumatriptan Subcutaneous
- Sumatriptan and naproxen-Molindone
- Sumatriptan and naproxen-Mometasone (Oral Inhalation)
- Sumatriptan and naproxen-Mometasone and Formoterol
- Sumatriptan and naproxen-Mometasone and formoterol Inhalation
- Sumatriptan and naproxen-Mometasone Cream
- Sumatriptan and naproxen-Mometasone Furoate